跳至主要内容
临床试验/IRCT20221215056828N1
IRCT20221215056828N1招募中3 期

Effect of Butyrate on anti inflammatory genes Sirt1 and Pgc1alpha and apoptosis gene Bax and Bcl2 in Ulcerative colitis patients

Shiraz University of Medical Sciences0 个研究点目标入组 30 人开始时间: 待定最近更新:
适应症

试验速览

阶段
3 期
状态
招募中
入组人数
30

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 years 至 60 years(—)
性别
All

入选标准

  • •Male or female 18 to 60 years old
  • •Body mass index between 18.5 and 30
  • •Estimating the severity of the disease based on the Mayo
  • •The severity of the disease is mild to moderate
  • •Patients with ulcerative colitis diagnosed by colonoscopy
  • •Informed consent from the patient
  • •Patients who are in the quiescent stage of the disease are included in the study, and patients who are in the acute stage of the disease are excluded.
  • •The patient should refrain from any self treatment and use of herbal medicines.

排除标准

  • •Patients with other gastrointestinal diseases including intestinal obstruction, fistula, celiac disease, cancer and infectious diseases
  • •Pregnancy and breastfeeding
  • •Use of antibiotic drugs and other probiotic products and vitamin and mineral supplements for the previous 2 months.
  • •History of hospitalization in the last 3 months
  • •Type 2 diabetes patients
  • •Acute stage of the disease
  • •Change in the process of drug consumption during the study
  • •Intensification of the disease during study
  • •The place of implementation of the study is Faqihi Hospital and Motahari Clinic of Shiraz University of Medical Sciences

研究者

相似试验